Could Proteomics Reveal Hidden Activity in MS and Parkinson’s Disease?
Personalized briefing
Discovery of the day · Neurology
The most significant scientific discovery today
Dear Kelly M Leyden — curated for your work in Neurology.
Key finding
Medicine · Neurology · Proteomics
Discovery of the day
Proteomic signatures of disease activity and progression in multiple sclerosis: A systematic review
This systematic review synthesizes the latest evidence on blood-based proteomic biomarkers for tracking disease activity and progression in multiple sclerosis. The researchers identified distinct protein signatures that correlate with clinical and radiological measures of disease course. For your focus on neurodegenerative diseases and clinical actionability, these findings underscore the translational potential of proteomic assays to complement imaging and sensor-based multimodal monitoring in MS and related conditions.
Novelty
85%
Rigor
82%
Significance
92%
Validity
80%
Clarity
90%
Sponsored
Source lab and medical equipment directly from China — verified suppliers, no middlemen
ScientificChina connects research institutions and procurement teams with trusted Chinese manufacturers of lab instruments, medical devices, and scientific equipment — at a fraction of Western market prices.
Update your briefing preferences
Stay curious. Stay informed —
Science Briefing
Your briefing is personalized based on your selected fields, keywords, and research interests.
